Literature DB >> 8987091

Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.

J K Buolamwini1, K Raghavan, M R Fesen, Y Pommier, K W Kohn, J N Weinstein.   

Abstract

PURPOSE: A QSAR study based on electrotopological state (E-state) indices was conducted for a series of flavone HIV-1 integrase inhibitors to guide drug design.
METHODS: E-state indices formulated to encode electronic and topological information for each skeletal atom in a molecule (Kier and Hall Pharm. Res. 7:801-807 (1990)) were calculated using the Molconn-X program, and partial least squares (PLS) multivariate regression was used to derive QSAR models.
RESULTS: Predictive models with correlation coefficients (r2) of 0.98 (3 PLS components) and 0.99 (5 PLS components) and corresponding cross-validated correlation coefficients (c.v. r2) of 0.51 and 0.73, were obtained for inhibition of cleavage and integration, respectively, with one molecule omitted from the analysis.
CONCLUSIONS: E-state indices at C6, C3', C5', C5, and O4 were found to be more important for prediction of activity than those for any of the other 12 flavone skeletal atoms that are common to the molecules in the data set.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987091     DOI: 10.1023/a:1016005813432

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  An electrotopological-state index for atoms in molecules.

Authors:  L B Kier; L H Hall
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

3.  Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.

Authors:  K Raghavan; J K Buolamwini; M R Fesen; Y Pommier; K W Kohn; J N Weinstein
Journal:  J Med Chem       Date:  1995-03-17       Impact factor: 7.446

4.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

Authors:  F Dyda; A B Hickman; T M Jenkins; A Engelman; R Craigie; D R Davies
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

5.  Hydroxylated aromatic inhibitors of HIV-1 integrase.

Authors:  T R Burke; M R Fesen; A Mazumder; J Wang; A M Carothers; D Grunberger; J Driscoll; K Kohn; Y Pommier
Journal:  J Med Chem       Date:  1995-10-13       Impact factor: 7.446

Review 6.  Present status and future prospects for HIV therapies.

Authors:  M I Johnston; D F Hoth
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

7.  Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.

Authors:  F D Bushman; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

8.  Inhibitors of human immunodeficiency virus integrase.

Authors:  M R Fesen; K W Kohn; F Leteurtre; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells.

Authors:  R L LaFemina; C L Schneider; H L Robbins; P L Callahan; K LeGrow; E Roth; W A Schleif; E A Emini
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds.

Authors:  M R Fesen; Y Pommier; F Leteurtre; S Hiroguchi; J Yung; K W Kohn
Journal:  Biochem Pharmacol       Date:  1994-08-03       Impact factor: 5.858

View more
  3 in total

Review 1.  Computer tools in the discovery of HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

2.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

3.  3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.

Authors:  Haregewein Assefa; Shantaram Kamath; John K Buolamwini
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.